Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 1

Conditions

Ovarian Neoplasms 24Fallopian Tube Neoplasms 13Neoplasms 11Breast Neoplasms 11Triple Negative Breast Neoplasms 5Carcinoma, Ovarian Epithelial 5Solid Tumors 4Sarcoma 4Neoplasm Metastasis 4Sarcoma, Ewing 3Lymphoma 3Carcinoma 3Sarcoma, Kaposi 2Rhabdomyosarcoma 2Recurrence 2Osteosarcoma 2Multiple Myeloma 2Lymphoma, T-Cell 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Advanced Solid Tumors 2AIDS-related Kaposi sarcoma 2Urinary Bladder Neoplasms 1Unrecognized Condition 1Subcutaneous panniculitis-like T-cell lymphoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1

Interventions

Cyclophosphamide 9Topotecan 5Temozolomide 5Melphalan 5Irinotecan 5Busulfan 5fludarabine 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4liposomal doxorubicin 3fludarabine phosphate 3cabozantinib 3Vincristine 3regorafenib 2pegfilgrastim 2Sirolimus 2Doxorubicin 2Bone Marrow Transplantation 2trioctyl phosphine oxide 1trifluridine tipiracil drug combination 1thymoglobulin 1talazoparib 1selinexor 1seclidemstat 1racotumomab 1poly ICLC 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1olaparib 1niraparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma, Ewing × liposomal doxorubicin × Clear all
NCT05210374 2026-06-05

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Case Comprehensive Cancer Center

Phase 1 Recruiting
24 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
15 enrolled
Sarcoma

Sarcoma, Ewing

NCT02557854 2019-03-19

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

University of Texas Southwestern Medical Center

Phase 1 Withdrawn
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡